SCHEMBL4340674

SCHEMBL4340674

O=C[N+](c1c(C(=O)Nc2ccc(Cl)cn2)oc2ccccc12)(C1CCNCC1)C1CCNCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.56
▸ NPC1 O15118 7/20 0.43
▸ RAB9A P51151 7/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2944372 0.78 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL2939976 0.78 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL4340675 0.75 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL2945692 0.72 SMN1; SMN2 (0.74) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL13744688 0.71 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AKDM4ETP53
SCHEMBL13515748 0.70 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL4312968 0.70 KMT2A (0.62) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL4312980 0.70 KMT2A (0.62) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
SCHEMBL13744493 0.69 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AKDM4ENFKB1
Hydrochloric Acid SCHEMBL2943708 0.69 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AKDM4ENFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 SMN1; SMN2 3067/4885NPC1 3431/4885RAB9A 4600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback